- Home
- FEMY
FEMY
Femasys Inc.
as 07-26-2024 4:00pm EST
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics.
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | SUWANEE |
| Market Cap: | 25.3M | IPO Year: | 2021 |
| Target Price: | $10.50 | AVG Volume (30 days): | 123.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.84 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.25 - $4.75 | Next Earning Date: | 08-08-2024 |
| Revenue: | $1,049,126 | Revenue Growth: | -11.00% |
| Revenue Growth (this year): | 303.46% | Revenue Growth (next year): | 214.77% |
Latest Femasys Inc. News
FEMY Breaking Stock News: Dive into FEMY Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Femasys to Participate in European Society of Human Reproduction and Embryology 40th Annual Meeting in Amsterdam
Medical Device Network
a month ago
Femasys gains CE Mark approval for women’s health products
MT Newswires
a month ago
Femasys Secures CE Mark Approvals for Four Women's Health Products; Shares Up Over 14%
GlobeNewswire
a month ago
Femasys Receives CE Mark Approval for Four of its Women’s Health Products Clearing the Path for the Company to Begin Commercialization Efforts in Europe
GlobeNewswire
2 months ago
Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Office of Science and Technology Policy to Discuss the Cancer Moonshot Initiative
GlobeNewswire
2 months ago
Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Gender Policy Council
Zacks
3 months ago
Femasys Inc. (FEMY) Reports Q1 Loss, Misses Revenue Estimates
GlobeNewswire
3 months ago
Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate Update
Compare FEMY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "FEMY Femasys Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.